Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 57, Issue 2, 2016, Pages 152-160

  Wilmot, Beth ^a   Fry, Rebecca ^b   Smeester, Lisa ^b   Musser, Erica D ^c   Mill, Jonathan ^d,e   Nigg, Joel T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ADHD; epigenetic; methylation

Indexed keywords

BIOLOGICAL MARKER; MYT1L PROTEIN, HUMAN; NERVE PROTEIN; TRANSCRIPTION FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VIPR2 PROTEIN, HUMAN;

ATTENTION DEFICIT DISORDER; CHILD; CPG ISLAND; DNA METHYLATION; GENETICS; HUMAN; MALE; METABOLISM; PILOT STUDY; SALIVA;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOMARKERS; CHILD; CPG ISLANDS; DNA METHYLATION; HUMANS; MALE; NERVE TISSUE PROTEINS; PILOT PROJECTS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; SALIVA; TRANSCRIPTION FACTORS;

EID: 84940093457     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/jcpp.12457     Document Type: Article

References (65)

1. Aberg, K.A., McClay, J.L., Nerella, S., Clark, S., Kumar, G., Chen, W., … & Van den Oord, E.J. (2014). Methylome-wide association study of schizophrenia: Identifying blood biomarker signatures of environmental insults. JAMA Psychiatry, 71, 255–264.
2. Aberg, K.A., Xie, L.Y., McClay, J.L., Nerella, S., Vunck, S., Snider, S., … & Van den Oord, E.J. (2013). Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics, 5, 367–377.
3. Ahn, S.J., Costa, J., & Emanuel, J.R. (1996). PicoGreen quantitation of DNA: Effective evaluation of samples pre- or post-PCR. Nucleic Acids Research, 24, 2623–2625.
4. Bain, E.E., Apostol, G., Sangal, R.B., Robieson, W.Z., McNeill, D.L., Abi-Saab, W.M., & Saltarelli, M.D. (2012). A randomized pilot study of the efficacy and safety of ABT-089, a novel alpha4beta2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 73, 783–789.
5. Barfield, R.T., Almli, L.M., Kilaru, V., Smith, A.K., Mercer, K.B., Duncan, R., … & Conneely, K.N. (2014). Accounting for population stratification in DNA methylation studies. Genetic Epidemiology, 38, 231–241.
6. Barfield, R.T., Kilaru, V., Smith, A.K., & Conneely, K.N. (2012). CpGassoc: An R function for analysis of DNA methylation microarray data. Bioinformatics, 28, 1280–1281.
7. Beri, S., Bonaglia, M.C., & Giorda, R. (2013). Low-copy repeats at the human VIPR2 gene predispose to recurrent and nonrecurrent rearrangements. European Journal of Human Genetics, 21, 757–761.
8. Berko, E.R., Suzuki, M., Beren, F., Lemetre, C., Alaimo, C.M., Calder, R.B., … & Greally, J.M. (2014). Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLoS Genetics, 10, e1004402.
9. Bhatia, H.S., Agrawal, R., Sharma, S., Huo, Y.X., Ying, Z., & Gomez-Pinilla, F. (2011). Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PLoS ONE, 6, e28451.
10. Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., … & Shen, R. (2011). High density DNA methylation array with single CpG site resolution. Genomics, 98, 288–295.
11. Chaste, P., Clement, N., Botros, H.G., Guillaume, J.L., Konyukh, M., Pagan, C., … & Bourgeron, T. (2011). Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. Journal of Pineal Research, 51, 394–399.
12. Chen, Y.A., Lemire, M., Choufani, S., Butcher, D.T., Grafodatskaya, D., Zanke, B.W., … & Weksberg, R. (2013). Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics, 8, 203–209.
13. Chen, H.F., & Su, H.M. (2013). Exposure to a maternal n-3 fatty acid-deficient diet during brain development provokes excessive hypothalamic-pituitary-adrenal axis responses to stress and behavioral indices of depression and anxiety in male rat offspring later in life. Journal of Nutritional Biochemistry, 24, 70–80.
14. Davies, M.N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., … & Mill, J. (2012). Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biology, 13, R43.
15. Dempster, E.L., Pidsley, R., Schalkwyk, L.C., Owens, S., Georgiades, A., Kane, F., … & Mill, J. (2011). Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Human Molecular Genetics, 20, 4786–4796.
16. Duncan, L.E., & Keller, M.C. (2011). A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. American Journal of Psychiatry, 168, 1041–1049.
17. Eppig, J.T., Blake, J.A., Bult, C.J., Kadin, J.A., & Richardson, J.E. (2012). The Mouse Genome Database (MGD): Comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Research, 40(Database issue), D881–D886.
18. Garcia-Olivares, J., Torres-Salazar, D., Owens, W.A., Baust, T., Siderovski, D.P., Amara, S.G., … & Torres, G.E. (2013). Inhibition of dopamine transporter activity by G protein betagamma subunits. PLoS ONE, 8, e59788.
19. Gatti, D.M., Barry, W.T., Nobel, A.B., Rusyn, I., & Wright, F.A. (2010). Heading down the wrong pathway: On the influence of correlation within gene sets. BMC Genomics, 11, 574.
20. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., … & Zhang, J. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology, 5, R80.
21. Goeman, J.J., & Buhlmann, P. (2007). Analyzing gene expression data in terms of gene sets: Methodological issues. Bioinformatics, 23, 980–987.
22. Gow, R.V., & Hibbeln, J.R. (2014). Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child and Adolescent Psychiatric Clinics of North America, 23, 555–590.
23. Grupe, M., Paolone, G., Jensen, A.A., Sandager-Nielsen, K., Sarter, M., & Grunnet, M. (2013). Selective potentiation of (alpha4)3(beta2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Biochemical Pharmacology, 86, 1487–1496.
24. Gu, Z., Cheng, J., Zhong, P., Qin, L., Liu, W., & Yan, Z. (2014). Abeta selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: Implication in Alzheimer's disease. Journal of Neuroscience, 34, 13614–13628.
25. Hawkey, E., & Nigg, J.T. (2014). Omega-3 fatty acid and ADHD: Blood level analysis and meta-analytic extension of supplementation trials. Clinical Psychology Review, 34, 496–505.
26. Heijmans, B.T., & Mill, J. (2012). Commentary: The seven plagues of epigenetic epidemiology. International Journal of Epidemiology, 41, 74–78.
27. Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biology, 14, R115.
28. Houseman, E.A., Molitor, J., & Marsit, C.J. (2014). Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics, 30, 1431–1439.
29. Hung, J.H., Yang, T.H., Hu, Z., Weng, Z., & DeLisi, C. (2012). Gene set enrichment analysis: Performance evaluation and usage guidelines. Briefings in Bioinformatics, 13, 281–291.
30. Janssen, C.I., Zerbi, V., Mutsaers, M.P., de Jong, B.S., Wiesmann, M., Arnoldussen, I.A., … & Kiliaan, A.J. (2015). Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice. Journal of Nutritional Biochemistry, 26, 24–35.
31. Kamburov, A., Stelzl, U., Lehrach, H., & Herwig, R. (2013). The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Research, 41(Database issue), D793–D800.
32. Khatri, P., Sirota, M., & Butte, A.J. (2012). Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Computational Biology, 8, e1002375.
33. Krueger, F., & Andrews, S.R. (2011). Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics, 27, 1571–1572.
34. Lee, C.T., Fuemmeler, B.F., McClernon, F.J., Ashley-Koch, A., & Kollins, S.H. (2013). Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood. Addictive Behaviors, 38, 2683–2689.
35. Lesch, K.P., Merker, S., Reif, A., & Novak, M. (2013). Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD. European Neuropsychopharmacology, 23, 479–491.
36. Levinson, D.F., Duan, J., Oh, S., Wang, K., Sanders, A.R., Shi, J., … & Gejman, P.V. (2011). Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. American Journal of Psychiatry, 168, 302–316.
37. Mooney, M.A., Nigg, J.T., McWeeney, S.K., & Wilmot, B. (2014). Functional and genomic context in pathway analysis of GWAS data. Trends in Genetics, 30, 390–400.
38. Nagel, B.J., Bathula, D., Herting, M., Schmitt, C., Kroenke, C.D., Fair, D., & Nigg, J.T. (2011). Altered white matter micro-structure in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 283–292.
39. Nelson, A.B., Bussert, T.G., Kreitzer, A.C., & Seal, R.P. (2014). Striatal cholinergic neurotransmission requires VGLUT3. Journal of Neuroscience, 34, 8772–8777.
40. Nigg, J., Nikolas, M., & Burt, S.A. (2010). Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 863–873.
41. Ohmura, Y., Tsutsui-Kimura, I., & Yoshioka, M. (2012). Impulsive behavior and nicotinic acetylcholine receptors. Journal of Pharmacological Sciences, 118, 413–422.
42. Pancani, T., Bolarinwa, C., Smith, Y., Lindsley, C.W., Conn, P.J., & Xiang, Z. (2014). M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses. ACS Chemical Neuroscience, 5, 318–324.
43. Pidoplichko, V.I., Prager, E.M., Aroniadou-Anderjaska, V., & Braga, M.F. (2013). alpha7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability. Journal of Neurophysiology, 110, 2358–2369.
44. Pidsley, R., Viana, J., Hannon, E., Spiers, H.H., Troakes, C., Al-Saraj, S., … & Mill, J. (2014). Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biology, 15, 483.
45. Pidsley, R., Wong, C.C.Y., Volta, M., Lunnon, K., Mill, J., & Schalkwyk, L.C. (2013). A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics, 14, 293.
46. Potter, A.S., Dunbar, G., Mazzulla, E., Hosford, D., & Newhouse, P.A. (2014). AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adults. Biological Psychiatry, 75, 207–214.
47. Puig-Antich, J. & Ryan, N. (1996). Kiddie schedule for affective disorders and schizophrenia. Pittsburgh, PA: Western Psychiatric Institute.
48. Purcell, S. (2002). Variance components models for gene-environment interaction in twin analysis. Twin Research, 5, 554–571.
49. Rakyan, V.K., Down, T.A., Balding, D.J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12, 529–541.
50. Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., & Smyth, G.K. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43, e47. doi:10.1093/nar/gkv007
51. Sheward, W.J., Naylor, E., Knowles-Barley, S., Armstrong, J.D., Brooker, G.A., Seckl, J.R., … & Harmar, A.J. (2010). Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: Behavioral effects are more significant than direct outputs. PLoS ONE, 5, e9783.
52. Soria, V., Martinez-Amoros, E., Escaramis, G., Valero, J., Perez-Egea, R., Garcia, C., … & Urretavizcaya, M. (2010). Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology, 35, 1279–1289.
53. Sterley, T.L., Howells, F.M., & Russell, V.A. (2014). Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat. Brain Research, 1572, 1–10.
54. Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H.H., Peoples, A., … & Sebat, J. (2011). Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature, 471, 499–503.
55. van Mil, N.H., Steegers-Theunissen, R.P., Bouwland-Both, M.I., Verbiest, M.M., Rijlaarsdam, J., Hofman, A., … & Tiemeier, H. (2014). DNA methylation profiles at birth and child ADHD symptoms. Journal of Psychiatric Research, 49, 51–59.
56. Wallace, T.L., & Bertrand, D. (2013). Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochemical Pharmacology, 85, 1713–1720.
57. Wang, T., Zeng, Z., Li, T., Liu, J., Li, J., Li, Y., … & Shi, Y. (2010). Common SNPs in myelin transcription factor 1-like (MYT1L): Association with major depressive disorder in the Chinese Han population. PLoS ONE, 5, e13662.
58. Wechsler, D. (2003). Wechsler intelligence scale for children: Administration and scoring manual (4th edn). San Antonio, TX: Psychological Corporation.
59. Widenhorn-Muller, K., Schwanda, S., Scholz, E., Spitzer, M., & Bode, H. (2014). Effect of supplementation with long-chain omega-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled inter-vention trial. Prostaglandins Leukotrienes and Essential Fatty Acids, 91, 49–60.
60. Williams, N.M., Franke, B., Mick, E., Anney, R.J., Freitag, C.M., Gill, M., … & Faraone, S.V. (2012). Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. American Journal of Psychiatry, 169, 195–204.
61. Wong, C.C., Meaburn, E.L., Ronald, A., Price, T.S., Jeffries, A.R., Schalkwyk, L.C., & Mill, J. (2013). Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Molecular Psychiatry, 23, 41.
62. Wu, D., Lim, E., Vaillant, F., Asselin-Labat, M.L., Visvader, J.E., & Smyth, G.K. (2010). ROAST: Rotation gene set tests for complex microarray experiments. Bioinformatics, 26, 2176–2182.
63. Wu, D., & Smyth, G.K. (2012). Camera: A competitive gene set test accounting for inter-gene correlation. Nucleic Acids Research, 40, e133.
64. Xie, K., Ge, S., Collins, V.E., Haynes, C.L., Renner, K.J., Meisel, R.L., … & Martemyanov, K.A. (2012). Gbeta5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems. Psycho-pharmacology (Berl), 219, 823–834.
65. Xu, Y., Chen, X.T., Luo, M., Tang, Y., Zhang, G., Wu, D., … & Wang, H.L. (2015). Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children. Journal of Psychiatric Research, 64, 40–50.